Ming‐Hong Tai

4.0k citations
116 papers · 3.2k indexed · h-index 32
Topics
Fibroblast Growth Factor Research (12 papers)Angiogenesis and VEGF in Cancer (9 papers)Liver physiology and pathology (8 papers)

In The Last Decade

Ming‐Hong Tai

112 papers receiving 3.1k citations

Peers

Ming‐Hong Tai
Comparison fields: 5 of 138
  • Molecular Biology 1.6k
  • Oncology 583
  • Cancer Research 557
  • Surgery 340
  • Epidemiology 305
Replace Sachiko Yamaguchi with:
Sachiko Yamaguchi Japan
Bangyan L. Stiles United States
Takaaki Takeda Japan
Stefania Gelmini Italy
Dongmei Lai China
Guoying Wang China
Laura C. Greaves United Kingdom
James F. Callahan United States
Yunlong Yang China
Junichi Hamada Japan
Ming‐Hong Tai relative to Sachiko Yamaguchi Japan Sachiko Yamaguchi's profile →
Citations per field
00.5×
Sachiko Yamaguchi · 1×
Citations per year

Countries citing papers authored by Ming‐Hong Tai

Since Specialization
Citations

This map shows the geographic impact of Ming‐Hong Tai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming‐Hong Tai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming‐Hong Tai more than expected).

Fields of papers citing papers by Ming‐Hong Tai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming‐Hong Tai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming‐Hong Tai. The network helps show where Ming‐Hong Tai may publish in the future.

Co-authorship network of co-authors of Ming‐Hong Tai

This figure shows the co-authorship network connecting the top 25 collaborators of Ming‐Hong Tai. A scholar is included among the top collaborators of Ming‐Hong Tai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming‐Hong Tai. Ming‐Hong Tai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 6
2 3
3 4
4 7
5 2
6 18
7 2
8 9
9 10
10 39
11 51
12 5
13 21
14 17
15 11
16 16
17 12
18 27
19 23
20
HDGF overexpression enhances the tumorigenicity of hepatocellular carcinoma
1

About Ming‐Hong Tai

Ming‐Hong Tai is a scholar working on Hepatology, Ophthalmology and Cell Biology, having authored 116 papers that have together received 3.2k indexed citations. Recurring topics across this work include Fibroblast Growth Factor Research (12 papers), Angiogenesis and VEGF in Cancer (9 papers) and Liver physiology and pathology (8 papers). The work is most often cited by research in Cancer Research (557 citations), Hepatology (262 citations) and Molecular Biology (1.6k citations). Ming‐Hong Tai has collaborated with scholars based in Taiwan, Australia and United States. Frequent co-authors include Zhi‐Hong Wen, Jian‐Ching Wu, Chi‐Sin Changchien, Mei‐Lang Kung, Chao‐Cheng Huang, Tsung‐Hui Hu, Tian‐Huei Chu, Hsiao‐Mei Kuo, Chuan–Mo Lee and Tsung‐Hui Hu. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026